 | Up a level |
Oneda, B; Crettol, S; Bochud, M; Besson, J; Croquette-Krokar, M; Hämmig, R; Monnat, M; Preisig, M; Eap, C B (2011). β-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics journal, 11(4), pp. 258-66. Basingstoke: Nature Publishing Group 10.1038/tpj.2010.37
Hallinan, R; Crettol, S; Agho, K; Attia, J; Besson, J; Croquette-Krokar, M; Hämmig, R; Déglon, J.J.; Byrne, A; Ray, J; Somogyi, A.A.; Eap, C.B. (2009). Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study. European journal of clinical pharmacology, 65(11), pp. 1113-1120. Berlin: Springer 10.1007/s00228-009-0706-8
Crettol, S; Besson, J; Croquette-Krokar, M; Hämmig, R; Gothuey, I; Monnat, M; Déglon, J.J.; Preisig, M; Eap, C.B. (2008). Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Progress in neuro-psychopharmacology & biological psychiatry, 32(7), pp. 1722-1727. Amsterdam: Elsevier 10.1016/j.pnpbp.2008.07.009
Crettol, S; Déglon, J.J.; Besson, J; Croquette-Krokar, M; Hämmig, R; Gothuey, I; Monnat, M; Eap, C.B. (2008). No influence of ABCB1 haplotypes on methadone dosage requirement. Clinical pharmacology & therapeutics, 83(5), pp. 668-669. New York, N.Y.: Nature Publishing Group 10.1038/sj.clpt.6100305
